Johnson & Johnson today announced the nipocalimab Biologics License Application (BLA) received Priority Review designation from the U.S Food and Drug Administration (FDA) for the treatment ...

Abdera Therapeutics Inc., a clinical-stage biopharmaceutical company leveraging its advanced antibody engineering ROVErtm platform to design and develop tunable precision radiopharmaceuticals for ...

Agreement supports the research and development of up to five novel therapeutic antibodies identified through Alchemab's antibody discovery platform.

Researchers developed AbMAP, a cutting-edge framework leveraging transfer learning to model antibody hypervariable regions, ...

Invenra has launched its Rapid Antibody Discovery Service, designed to simplify and de-risk the preclinical development of ...

Mitazalimab is under clinical development by Alligator Bioscience and currently in Phase I for Pancreatic Cancer.

INR:6314. exploiting sports betting market using machine learning Science sub-journal publishes article using new anti-can ...

Live dealer blackjack BI 767551, a neutralizing antibody against the novel coronavirus, enters clinical trials Medical Insurance DRGs reform encou ...

INR:4956. stylish name 🦋⃟🇸 R&D Daily丨Junshi's COVID-19 neutralizing antibody enters Phase I clinical trial and completes first dosing FDA final ...

The WHO Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) continues to closely monitor the genetic and antigenic evolution of SARS-CoV-2 variants, immune responses to SARS-CoV-2 ...

This gap stems from the challenges of imaging small organisms, including poor antibody penetration and the resolution limits of conventional ... By characterizing cellular and cytoskeletal diversity, ...